Institutional case volume and mortality after aortic and mitral valve replacement: a nationwide study in two Korean

Karam Nam1, Eun Jin Jang2, Jun Woo Jo3

  • 1Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.

Insights

Higher heart valve surgery volume is linked to better patient survival. This study found lower mortality rates in high-volume centers for aortic valve replacement (AVR) and mitral valve replacement (MVR).

Area of Science:

  • Cardiovascular Surgery
  • Health Services Research
  • Outcomes Research

Background:

  • Limited research exists on the volume-outcome relationship in heart valve surgery.
  • This study investigates the association between hospital case volume and mortality for aortic valve replacement (AVR) and mitral valve replacement (MVR).

Purpose of the Study:

  • To determine if higher institutional case volumes correlate with lower in-hospital mortality rates after AVR and MVR.
  • To inform discussions on centralizing cardiac valve replacement procedures.

Main Methods:

  • Analysis of a Korean healthcare insurance database (2009-2016) for adult AVR and MVR cases.
  • Hospitals categorized into low, medium, and high volume based on annual case numbers for AVR and MVR.
  • Comparison of in-hospital mortality rates across different volume groups.

Main Results:

  • Higher in-hospital mortality observed in low- and medium-volume centers for both AVR and MVR compared to high-volume centers.
  • Adjusted risk of mortality was significantly higher in lower-volume centers for both procedures.
  • AVR: Low-volume (8.3%), Medium-volume (4.0%), High-volume (2.6%). MVR: Low-volume (9.3%), Medium-volume (6.3%), High-volume (2.9%).

Conclusions:

  • Lower institutional case volume is associated with increased in-hospital mortality after AVR and MVR.
  • Findings suggest potential benefits of regionalizing or centralizing cardiac valve replacement surgeries.
  • Optimizing patient outcomes may be achieved through strategic centralization of these procedures.
Abstract

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
38
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
44
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
28
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
31
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
25